NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia ...

The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

NEW ORLEANS, LA—Complete revascularization in patients presenting with ACS and multivessel coronary artery disease ...

For patients with aortic stenosis, is earlier intervention beneficial? Mamas Mamas, Philippe Généreux, Nicolas Van Mieghem, ...

The device may help boost early detection of HFrEF for people living in low-resource settings where echo is scarce.

Mortality/major ischemic events at 90 days were no lower than with a restrictive strategy—but cardiac complications differed.

NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) undergoing PCI, 1 month of dual therapy with a direct oral ...

An oral agent is needed because some patients don’t like injectables, and some doctors don’t prescribe them, experts say.

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.

The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be ...

DES, adding clopidogrel in the chronic phase of coronary disease had no ischemic benefit and increased bleeding.